# Efficacy and Safety of a Voltage-Guided Stepwise Strategy for Pulmonary Vein Isolation

Study · id `cardio:ct-nct07354737` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07354737](<https://clinicaltrials.gov/study/NCT07354737>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07354737

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 130 participants.

## Technical summary

Registry record NCT07354737. Randomized; double masking; primary purpose treatment. Start 2021-04-01 (actual); primary completion 2025-01-22 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 130 participants (enrolled count; ClinicalTrials.gov record NCT07354737, source copy `cardio:ctgov-nct07354737-2026-01-22`, retrieved 2026-10-26)
- Started: 2021-04-01 (actual) (ClinicalTrials.gov record NCT07354737, source copy `cardio:ctgov-nct07354737-2026-01-22`, retrieved 2026-10-26)
- Primary completion: 2025-01-22 (actual) (ClinicalTrials.gov record NCT07354737, source copy `cardio:ctgov-nct07354737-2026-01-22`, retrieved 2026-10-26)
- Completion: 2025-01-22 (actual) (ClinicalTrials.gov record NCT07354737, source copy `cardio:ctgov-nct07354737-2026-01-22`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT07354737, source copy `cardio:ctgov-nct07354737-2026-01-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07354737-2026-01-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy and Safety of a Voltage-Guided Stepwise Strategy for Pulmonary Vein Isolation
- Acronym: VoS-PVI
- Condition: Atrial Fibrillation (AF)
- Condition: Atrial Fibrillation Ablation Procedure
- Condition: Atrial Tachyarrhythmia Recurrence
- Condition: Esophageal Thermal Injury
- Intervention (Device): Radiofrequency ablation catheter system
- Intervention (Device): Radiofrequency ablation catheter system
- Lead sponsor: Ajou University School of Medicine
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Ajou University School of Medicine (`cardio:org-ajou-university-school-of-medicine`)

## Provenance

Content hash: bcfdd3068c09fc9f2c2f355aeba8131ada8b8d4dc420e9928fd5fd8c2f604450
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
